Technology

Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray

March 16, 2026 aptar investors relations contact: businesswire

Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma’s Intranasal Delivery System Used in Phase II Clinical Study Investigational SPONTAN® Nasal Spray

Read Full Article

This article was originally published on businesswire. Click the button above to read the complete article.